NEOCERA
Dead / Cancelled — Cancelled — Section 8 (as of 22 Nov 2024)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 87051082
- Registration number
- 5465153
- Mark type
- Design + words
- Filed
- 26 May 2016
- Published for opposition
- 24 Jan 2017
- Registered
- 08 May 2018
- Attorney of record
- Meghna Prasad
Goods and services
- Class 005 — Pharmaceuticals: Dermatological pharmaceutical products; pharmaceutical preparations for treating skin disorders; pharmaceutical preparations for use in dermatology; medicated topical skin care preparations
Owner
- RESILIA PHARMACEUTICALS, INC., NEW YORK, NY, US
- GLENMARK THERAPEUTICS INC., USA, MAHWAH, NJ, US
- Exeltis USA, Inc., Chatham, NJ, US
- Exeltis USA, Inc., Chatham, NJ, US
- Exeltis USA, Inc., Chatham, NJ, US
Prosecution history
- 22 Nov 2024 — CANCELLED SEC. 8 (6-YR)
- 08 May 2023 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 08 Jun 2022 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 03 Jun 2022 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 03 Jun 2022 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 03 Jun 2022 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 03 Jun 2022 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 03 Jun 2022 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 05 May 2021 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 29 Apr 2021 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 23 Jan 2019 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 08 May 2018 — REGISTERED-PRINCIPAL REGISTER
- 05 Apr 2018 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 04 Apr 2018 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 21 Mar 2018 — STATEMENT OF USE PROCESSING COMPLETE